RB Capital Management’s AbbVie ABBV Stock Holding History

RB Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.65M	Buy	14,253 +192	+1%	+$35.6K	0.6%	41
2025 Q1	$2.95M	Buy	14,061 +192	+1%	+$40.2K	0.68%	34
2024 Q4	$2.46M	Sell	13,869 -270	-2%	-$48K	0.56%	42
2024 Q3	$2.79M	Buy	14,139 +26	+0.2%	+$5.13K	0.65%	37
2024 Q2	$2.42M	Buy	14,113 +62	+0.4%	+$10.6K	0.6%	41
2024 Q1	$2.56M	Buy	14,051 +610	+5%	+$111K	0.67%	36
2023 Q4	$2.08M	Sell	13,441 -273	-2%	-$42.3K	0.6%	40
2023 Q3	$2.04M	Buy	13,714 +425	+3%	+$63.4K	0.64%	39
2023 Q2	$1.79M	Buy	13,289 +474	+4%	+$63.9K	0.54%	43
2023 Q1	$2.04M	Buy	12,815 +669	+6%	+$107K	0.65%	40
2022 Q4	$1.96M	Buy	12,146 +426	+4%	+$68.8K	0.69%	37
2022 Q3	$1.57M	Buy	11,720 +1,536	+15%	+$206K	0.6%	40
2022 Q2	$1.56M	Buy	10,184 +1,069	+12%	+$164K	0.58%	45
2022 Q1	$1.48M	Buy	9,115 +273	+3%	+$44.3K	0.47%	49
2021 Q4	$1.2M	Buy	8,842 +493	+6%	+$66.7K	0.37%	58
2021 Q3	$901K	Buy	8,349 +750	+10%	+$80.9K	0.34%	69
2021 Q2	$856K	Sell	7,599 -30	-0.4%	-$3.38K	0.32%	71
2021 Q1	$826K	Sell	7,629 -898	-11%	-$97.2K	0.36%	65
2020 Q4	$914K	Buy	8,527 +2,416	+40%	+$259K	0.42%	53
2020 Q3	$537K	Sell	6,111 -342	-5%	-$30.1K	0.25%	80
2020 Q2	$633K	Buy	6,453 +28	+0.4%	+$2.75K	0.34%	70
2020 Q1	$483K	Sell	6,425 -137	-2%	-$10.3K	0.31%	75
2019 Q4	$582K	Sell	6,562 -125	-2%	-$11.1K	0.33%	72
2019 Q3	$498K	Buy	6,687 +780	+13%	+$58.1K	0.32%	75
2019 Q2	$429K	Buy	5,907 +196	+3%	+$14.2K	0.31%	76
2019 Q1	$461K	Buy	5,711 +376	+7%	+$30.4K	0.38%	65
2018 Q4	$492K	Buy	5,335 +106	+2%	+$9.78K	0.5%	55
2018 Q3	$495K	Sell	5,229 -886	-14%	-$83.9K	0.44%	63
2018 Q2	$567K	Buy	6,115 +941	+18%	+$87.3K	0.42%	61
2018 Q1	$490K	Buy	5,174 +107	+2%	+$10.1K	0.39%	67
2017 Q4	$490K	Buy	5,067 +128	+3%	+$12.4K	0.35%	68
2017 Q3	$439	Sell	4,939 -375	-7%	-$33	0.01%	67
2017 Q2	$385K	Sell	5,314 -123	-2%	-$8.91K	0.33%	69
2017 Q1	$354K	Buy	5,437 +663	+14%	+$43.2K	0.34%	74
2016 Q4	$299K	Buy	+4,774	New	+$299K	0.3%	82